NovaBay Pharmaceuticals Inc (NBY) — Financial Flexibility Index
NovaBay Pharmaceuticals Inc (NBY) has a Financial Flexibility Index of -0.07x as of December 2025. Free cash flow of $-2.27 Million (operating CF $-2.27 Million minus capex $0.00) represents 0% of total liabilities ($31.86 Million). Check NBY cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NovaBay Pharmaceuticals Inc Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for NovaBay Pharmaceuticals Inc across 21 annual periods. For the full cash flow conversion analysis, see NovaBay Pharmaceuticals Inc cash flow conversion.
Annual Financial Flexibility Index for NovaBay Pharmaceuticals Inc (2005–2025)
Year-by-year free cash flow to debt coverage for NovaBay Pharmaceuticals Inc. Explore NovaBay Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.26x | $-8.43 Million | $-8.43 Million | $31.86 Million | ▲ +81.8% |
| 2024 | -1.46x | $-5.18 Million | $-5.18 Million | $3.55 Million | ▼ -96.5% |
| 2023 | -0.74x | $-4.24 Million | $-4.26 Million | $5.72 Million | ▲ +33.7% |
| 2022 | -1.12x | $-6.54 Million | $-6.65 Million | $5.84 Million | ▼ -69.1% |
| 2021 | -0.66x | $-9.14 Million | $-9.19 Million | $13.81 Million | ▲ +58.8% |
| 2020 | -1.61x | $-4.70 Million | $-4.72 Million | $2.92 Million | ▼ -108.3% |
| 2019 | -0.77x | $-7.91 Million | $-7.93 Million | $10.25 Million | ▲ +38.4% |
| 2018 | -1.25x | $-5.52 Million | $-5.57 Million | $4.41 Million | ▼ -55.7% |
| 2017 | -0.81x | $-6.03 Million | $-6.27 Million | $7.49 Million | ▲ +44.3% |
| 2016 | -1.45x | $-11.97 Million | $-12.13 Million | $8.28 Million | ▲ +20.2% |
| 2015 | -1.81x | $-18.44 Million | $-18.56 Million | $10.18 Million | ▲ +31.2% |
| 2014 | -2.63x | $-14.99 Million | $-15.05 Million | $5.69 Million | ▼ -46.5% |
| 2013 | -1.80x | $-12.83 Million | $-12.97 Million | $7.13 Million | ▼ -46.2% |
| 2012 | -1.23x | $-6.38 Million | $-6.53 Million | $5.19 Million | ▼ -169.4% |
| 2011 | -0.46x | $-3.02 Million | $-3.14 Million | $6.62 Million | ▼ -202.9% |
| 2010 | 0.44x | $2.23 Million | $2.03 Million | $5.03 Million | ▲ +302.2% |
| 2009 | -0.22x | $-917.00K | $-1.65 Million | $4.18 Million | ▲ +84.4% |
| 2008 | -1.41x | $-9.33 Million | $-9.94 Million | $6.62 Million | ▼ -141.2% |
| 2007 | -0.58x | $-5.61 Million | $-6.27 Million | $9.60 Million | ▼ -215.0% |
| 2006 | 0.51x | $5.11 Million | $4.74 Million | $10.05 Million | ▲ +105.1% |
| 2005 | -10.02x | $-3.11 Million | $-3.23 Million | $310.00K | — |